Spinogenix, Inc.

Carlsbad, CA

UEI
G2JEUT716287
CAGE
7PQF7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
8135 Paseo Taxco, Carlsbad, CA 92009, USA
Website
spinogenix.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A 13 week GLP toxicology study with SPG302 in beagle dogs HT94252310580 Defense Health Agency $949,108
Development of a novel, regenerative therapy to reverse synapse loss in alzheimer's disease R44AG082648 National Institute on Aging (NIH) $4,414,120
Novel small molecules that target alzheimer's disease by increasing spinogenesis and decreasing a-beta toxicity R43AG058278 National Institute on Aging (NIH) $314,511

Quick answers

Is Spinogenix, Inc. registered in SAM.gov?

Yes. Spinogenix, Inc.'s SAM.gov registration is active through September 21, 2027.

What is Spinogenix, Inc.'s most recent federal award?

Spinogenix, Inc.'s most recent federal grant award is A 13 week GLP toxicology study with SPG302 in beagle dogs (HT94252310580), from Defense Health Agency, on August 1, 2023.

On GovTribe

See Spinogenix, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login